Operator: Good afternoon, and welcome to the Cyclacel Pharmaceuticals Third Quarter 2023 Results Conference Call and Webcast. [Operator Instructions] Please note, today s call is being recorded.
StockNews.com assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a research note issued to investors on Friday. The firm issued a sell rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Stock Performance Shares of CYCC stock opened at $0.35 on Friday. Cyclacel Pharmaceuticals has a 52-week low of $0.28 and a […]
StockNews.com began coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a report issued on Wednesday morning. The firm issued a sell rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Stock Performance Shares of NASDAQ:CYCC opened at $0.32 on Wednesday. The company’s fifty day moving average is $0.51 and its 200-day moving average […]